As expected for breast cancers [17], mutational profiles of primary tumors included AKT1, CDH1, ERBB2, GATA3, MLL3/KMT2C, PIK3CA, and TP53 mutations (Figure 3). This evidence concerns the gene KMT2C and breast carcinoma.